Sideroblastic anemia

00:00 / 00:00



Sideroblastic anemia

Hematological system

Coagulation disorders


Vitamin K deficiency

Leukemoid reaction

Leukemoid reaction


Sideroblastic anemia


0 / 15 complete

USMLE® Step 1 questions

0 / 3 complete

High Yield Notes

4 pages


Sideroblastic anemia

of complete


USMLE® Step 1 style questions USMLE

of complete

A 40-year-old man comes to the office because of fever, cough, and night sweats. The patient has felt fatigued over the past six-months and has experienced a 15 lb (6.8 kg) weight loss. Past medical history is significant for hypertension and hyperlipidemia. Temperature is 37.7°C (99.9°F), pulse is 78/min, respirations are 17/min, and blood pressure is 142/88 mmHg. A chest radiograph shows a cavitary lesion in the left upper lobe and an interferon-gamma release assay is positive. The patient is started on appropriate antimicrobial therapy. Three months later, he is seen in the office for follow-up. Laboratory testing reveals the following results:

 Laboratory Value  Result (U.S. Conventional Units)  Results (S.I. Units) 
 Hemoglobin  9.2 g/dL  5.71 mmol/L 
 Leukocyte count  11,000/mm3  11.0*109/L 
 Platelet count    230,000/mm3  230*109/L 
 Mean corpuscular volume  75 μm3  75 fL 

A peripheral blood smear shows Pappenheimer bodies. Bone marrow aspirate is subsequently obtained and demonstrates the following:

Image reproduced from Wikimedia Commons

Which of the following processes is most likely impaired in this patient?

External References

First Aid








Alcoholism p. 595

sideroblastic anemia p. 427


sideroblastic p. 65

Anemias p. 425-417

ringed sideroblasts in p. 424

Basophilic stippling p. 424, 721

sideroblastic anemia p. 427

Ferritin p. 211

sideroblastic anemia p. 427


sideroblastic anemia and p. 427


sideroblastic anemia p. 427

Isoniazid p. 194

sideroblastic anemia p. 427

Lead poisoning p. 427, 432

sideroblastic anemia p. 427

Myelodysplastic syndromes p. 439

sideroblastic anemia p. 427

Ringed sideroblasts p. 424

Sideroblastic anemia p. 424, 427

in anemia taxonomy p. 425

labs/findings p. 721

lead poisoning p. 427

vitamin B6 deficiency p. 65

Sideroblasts p. 424

Vitamin B6

sideroblastic anemia p. 427


With sideroblastic anemia, sidero- means iron and -blastic meaning immature and anemia refers to a condition where there’s a decrease in the number of healthy red blood cells, or RBCs in the body.

So sideroblastic anemia is a type of blood disorder where there’s a buildup of iron in the RBC’s in the body causing them to be immature and dysfunctional.

This buildup occurs because these RBC’s are unable to incorporate iron into hemoglobin which is necessary for RBC’s to transport oxygen.

In order to better understand sideroblastic anemia, we need to first take a look at hemoglobin, the main protein within RBC’s that’s responsible for carrying oxygen.

Now hemoglobin is made up of hemes and globins.

There are 4 globin subunits, typically two alpha and two beta, and each one has its own heme group.

This heme is a large molecule that’s made up of four pyrrole subunits that forms a ring, and this structure is called a porphyrin.

In the middle, there is an ionically bond iron 2+ and the iron is what binds to and carries the oxygen molecule.

So each hemoglobin can carry four oxygen molecules when it’s fully saturated.

The process of heme synthesis occurs both within the mitochondria and the cytosol of a cell and requires multiple enzymes to catalyze the numerous steps.

It begins in the mitochondria where succinyl CoA binds to glycine via delta-ALA synthase which uses vitamin B6 as a cofactor to produce delta-aminolevulinic acid, or ALA.

Then, in the cytosol, delta-aminolevulinic acid is converted to porphobilinogen, or PBG, via delta-ALA dehydratase.

From there, four molecules of porphobilinogen condense together to form hydroxymethylbilane with the help of porphobilinogen deaminase.

Note that porphobilinogen deaminase is sometimes called uroporphyrinogen I synthase or hydroxymethylbilane synthase, or HMBS for short.

Afterwards, hydroxymethylbilane is converted to uroporphyrinogen III and catalyzed to coproporphyrinogen III via uroporphyrinogen III cosynthase and uroporphyrinogen decarboxylase, respectively.

Next, coproporphyrinogen III is brought back into the mitochondria and converted into protoporphyrinogen IX by coproporphyrinogen oxidase.

Protoporphyrinogen IX is converted to protoporphyrin IX by protoporphyrinogen oxidase.

Lastly, an iron molecule is added to protoporphyrin IX via the enzyme ferrochelatase, and 10 tongue twisters later, voila! We got ourselves a completed heme!


Sideroblastic anemia occurs when the bone marrow produces ringed sideroblasts rather than healthy red blood cells (erythrocytes). It is due to either a congenital abnormality or an acquired cause such as vitamin B6 deficiency, excessive alcohol use, or lead poisoning which leads to an inability to incorporate iron to form heme.

The lack of functional heme results in anemia and fatigue. Also, the overload of iron that is unable to be incorporated into RBCs can damage other organs. Diagnosis of sideroblastic anemia involves a medical history and physical examination, along with tests like full blood count and peripheral blood smear. Treatment involves the removal of toxins and the administration of vitamin B6, thiamine, and folic acid.


  1. "Pathophysiology of Disease: An Introduction to Clinical Medicine 8E" McGraw-Hill Education / Medical (2018)
  2. "X-Linked, Pyridoxine-Responsive Sideroblastic Anemia" New England Journal of Medicine (1994)
  3. "Robbins Basic Pathology" Elsevier (2017)
  4. "Sideroblastic anemias." Wintrobe's Clinical Hematology. 10th ed. (1999)
  5. "Sideroblastic Anemias" undefined (2020)

Copyright © 2023 Elsevier, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies.

Cookies are used by this site.

USMLE® is a joint program of the Federation of State Medical Boards (FSMB) and the National Board of Medical Examiners (NBME). COMLEX-USA® is a registered trademark of The National Board of Osteopathic Medical Examiners, Inc. NCLEX-RN® is a registered trademark of the National Council of State Boards of Nursing, Inc. Test names and other trademarks are the property of the respective trademark holders. None of the trademark holders are endorsed by nor affiliated with Osmosis or this website.